Atlas Trials

A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589

Clinical trial NCT00472368 · COMPLETED

Trial details

NCT number
NCT00472368
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer Patients With Advanced Solid Tumors Including Lymphoma or Chronic Hematological Malignancies
Start date
2007-05-01
Primary completion
2008-06-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.